Innovative treatment of heart arrhytmias
EBAMed is a Geneva-based medical device company active in the ambitious field of proton therapy. The company is developing a novel treatment system to monitor and react to heart movement during cardiac radioablation procedures. The aim is to reduce the volume of healthy heart exposed to more than 20 gray of protons/photons during cardiac radio ablation, thereby maximizing long-term safety for patients.